Literature DB >> 4455126

Phosphorylation of kanamycin, lividomycin A, amd butirosin B by Providencia stuartii.

P B Marengo, M E Chenoweth, G D Overturf, J Wilkins.   

Abstract

The isolation of Providencia stuartii resistant to multiple aminoglycoside antibiotics prompted an investigation into the mechanism of their resistance. Crude enzyme extracts of a strain of P. stuartii inactivated kanamycin, lividomycin A, and butirosin B in the presence of adenosine 5'-triphosphate (ATP), as measured by a microbiological assay. The occurrence of inhibitory concentrations of 500 mug or greater per ml against kanamycin, lividomycin A, and butirosin B, coupled with the inactivation of these antibiotics in the presence of ATP, suggested enzymatic phosphorylation. This was documented by the transfer of the gamma-phosphate of [gamma-(32)P]ATP. In contrast, the inability to inactivate gentamicin or tobramycin by the crude enzyme extracts in the presence of ATP suggests another enzymatic mechanism of resistance for these antibiotics, such as adenylation or acetylation. Of importance is the fact that amikacin, a semisynthetic analogue of kanamycin A which is resistant to inactivation by most resistance transfer factor enzymes, was found to inhibit the growth of P. stuartii at low concentrations.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4455126      PMCID: PMC444743          DOI: 10.1128/AAC.6.6.821

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  A new enzyme in Escherichia coli carrying R-factor phosphorylating 3'-hydroxyl of butirosin A, kanamycin, neamine and ribostamycin.

Authors:  M Yagisawa; H Yamamoto; H Naganawa; S Kondo; T Takeuchi
Journal:  J Antibiot (Tokyo)       Date:  1972-12       Impact factor: 2.649

Review 2.  Mechanisms of antibiotic resistance in bacteria.

Authors:  R Benveniste; J Davies
Journal:  Annu Rev Biochem       Date:  1973       Impact factor: 23.643

3.  Microbiological evaluation of BB-K 8, a new semisynthetic aminoglycoside.

Authors:  K E Price; D R Chisholm; M Misiek; F Leitner; Y H Tsai
Journal:  J Antibiot (Tokyo)       Date:  1972-12       Impact factor: 2.649

4.  The problems of drug-resistant pathogenic bacteria. R factors: biochemical mechanisms of resistance to aminoglycoside antibiotics.

Authors:  J Davies; M Brzezinska; R Benveniste
Journal:  Ann N Y Acad Sci       Date:  1971-06-11       Impact factor: 5.691

5.  Aminoglycoside antibiotics: inactivation by phosphorylation in Escherichia coli carrying R factors.

Authors:  B Ozanne; R Benveniste; D Tipper; J Davies
Journal:  J Bacteriol       Date:  1969-11       Impact factor: 3.490

6.  Isolation and structure of kanamycin inactivated by a cell free system of kanamycin-resistant E. coli.

Authors:  H Umezawa; M Okanishi; R Utahara; K Maeda; S Kondo
Journal:  J Antibiot (Tokyo)       Date:  1967-07       Impact factor: 2.649

7.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

8.  In vitro reversal of antibiotic resistance by ethylenediamine tetraacetic acid.

Authors:  R Weiser; A W Asscher; J Wimpenny
Journal:  Nature       Date:  1968-09-28       Impact factor: 49.962

9.  Phosphorylation and inactivation of kanamycin by Pseudomonas aeruginosa.

Authors:  H Umezawa; O Doi; M Ogura; S Kondo; N Tanaka
Journal:  J Antibiot (Tokyo)       Date:  1968-02       Impact factor: 2.649

10.  Inactivation of kanamycin, neomycin, and streptomycin by enzymes obtained in cells of Pseudomonas aeruginoa.

Authors:  O Doi; M Ogura; N Tanaka; H Umezawa
Journal:  Appl Microbiol       Date:  1968-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.